Patent · US Active

Pharmaceutical compositions comprising DGLA and use of same

US9682055B2 · kind B2 · utility

7Cited by
2References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 4, 2015
Grant dateJun 20, 2017
Priority date
Expiry dateJun 4, 2035

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61Q19/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure provides orally deliverable pharmaceutical compositions comprising DGLA and to methods of using same to treat a variety of conditions and disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.